Hematology/Oncology

Top Story

Nonmelanoma skin cancer in children, young adults associated with risk factors

September 1, 2015

Almost half of children and young adults with nonmelanoma skin cancer were exposed to risk factors, according to recently published study results.

Researchers in Boston conducted a retrospective chart review of 28 children and young adults (aged 22 years or younger) with 182 nonmelanoma skin cancers (NMSCs) between 1993 and 2014. Seven patients were diagnosed with squamous cell carcinoma (SCC), 19 had basal cell carcinoma (BCC), and two patients were diagnosed with SCC and BCC.

In the Journals

Precision medicine techniques show promise for pediatric patients with relapsed, refractory cancer

September 1, 2015
The incorporation of integrative clinical sequencing data into the management of relapsed, refractory or rare cancers in children or young adults appeared feasible and…
In the Journals

Molecular prognostic index may predict survival in early-stage NSCLC

September 1, 2015
A nine-gene molecular prognostic index provided accurate risk stratification and may be used to inform adjuvant therapy for patients with early-stage non–small…
Julie M. Vose, MD, MBA, FASCO In the Journals

Rapid growth of genetic genomic testing leads to ASCO policy statement update

August 31, 2015
ASCO updated its policy statement on genetic and genomic testing for cancer susceptibility.The statement highlights the way new technologies have changed the assessment…

Regen developing new gene procedure for targeting liver cancer cells

August 31, 2015
Regen BioPharma, Inc. announced it is currently developing a gene delivery procedure that will enable RGBP-248, a gene silencing nucleic acid, to reach liver tumors and…
More News Headlines »
CME
Hematology Oncology Case Consults

The Patient with Chronic Lymphocytic Leukemia

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with chronic lymphocytic leukemia.
More »
Meeting News Coverage Video
VIDEO: PALOMA-3 trial represents 'enormous gain' for patients with hormone-positive breast cancer

VIDEO: PALOMA-3 trial represents 'enormous gain' for patients with hormone-positive breast cancer

August 20, 2015
CHICAGO — The PALOMA-3 trial, which evaluated the addition of palbociclib to fulvestrant, demonstrated…
More »
CME
Immunotherapy Updates 2015: FOCUS on NSCLC

Immunotherapy Updates 2015: FOCUS on NSCLC

This activity is supported by educational grants from Genentech, Inc. and Merck & Co., Inc.

Globally, lung cancer is the leading cause of cancer-related deaths. Non-small cell lung cancer (NSCLC) accounts for…
More »